Accolade/ACCD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Accolade

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Ticker

ACCD

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Rajeev Singh

Employees

2,400

Headquarters

Plymouth meeting, United States

Accolade Metrics

BasicAdvanced
$555M
Market cap
-
P/E ratio
-$1.34
EPS
2.10
Beta
-
Dividend rate
$555M
2.10418
$15.36
$6.33
643K
2.642
46.801
46.801
-11.80%
-21.71%
-13.63%
1.339
1.241
297.144
14.09%
79.63%
34.48%

What the Analysts think about Accolade

Analyst Ratings

Majority rating from 17 analysts.
Buy

Accolade Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.00% profit margin
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$125M
25.68%
Net income
-$7.5M
-64.29%
Profit margin
-6.00%
-71.62%

Accolade Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 41.30%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
-$0.52
-$0.43
-$0.28
-$0.10
-
Expected
-$0.62
-$0.54
-$0.44
-$0.07
-$0.48
Surprise
-16.12%
-19.84%
-36.67%
41.30%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Accolade stock?

Accolade (ACCD) has a market cap of $555M as of June 15, 2024.

What is the P/E ratio for Accolade stock?

The price to earnings (P/E) ratio for Accolade (ACCD) stock is 0 as of June 15, 2024.

Does Accolade stock pay dividends?

No, Accolade (ACCD) stock does not pay dividends to its shareholders as of June 15, 2024.

When is the next Accolade dividend payment date?

Accolade (ACCD) stock does not pay dividends to its shareholders.

What is the beta indicator for Accolade?

Accolade (ACCD) has a beta rating of 2.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Accolade stock price target?

The target price for Accolade (ACCD) stock is $13, which is NaN% below the current price of $. This is an average based on projections from 15 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Accolade stock

Buy or sell Accolade stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing